{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:32:13Z","timestamp":1787581933257,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115061","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:56:31Z","timestamp":1780012591000},"page":"115061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Achieving the goldilocks zone of lung-targeted mRNA delivery with a charge-steric optimized quantum dot-lipid system for pulmonary fibrosis therapy"],"prefix":"10.1016","volume":"396","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhekun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.jconrel.2026.115061_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci. Adv."},{"issue":"34","key":"10.1016\/j.jconrel.2026.115061_bb0010","article-title":"Lung cell transplantation for pulmonary fibrosis","volume":"10","author":"Krentsis","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24985-x","article-title":"Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGF\u03b2-induced lung fibrosis","volume":"12","author":"Ebrahimpour","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0020","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0025","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s41467-024-47460-9","article-title":"Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria","volume":"15","author":"Baek","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115061_bb0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41551-022-00989-w","article-title":"Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy","volume":"7","author":"You","year":"2023","journal-title":"Nature biomedical engineering."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115061_bb0035","article-title":"Inhaled mRNA nanoformulation with biogenic ribosomal protein reverses established pulmonary fibrosis in a bleomycin-induced murine model","volume":"34","author":"Zhang","year":"2022","journal-title":"Advanced Materials"},{"issue":"729","key":"10.1016\/j.jconrel.2026.115061_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh1334","article-title":"mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria","volume":"16","author":"Gurung","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115061_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202127","article-title":"Lipid nanoparticle delivery of chemically modified NGF(R100W) mRNA alleviates peripheral neuropathy","volume":"12","author":"Yu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115061_bb0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","article-title":"BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer\u2019s disease","volume":"7","author":"Phillips","year":"1991","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac581","article-title":"RNAdegformer: accurate prediction of mRNA degradation at nucleotide resolution with deep learning","volume":"24","author":"He","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115061_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115061_bb0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/acs.nanolett.9b04426","article-title":"Quantitating endosomal escape of a library of polymers for mRNA delivery","volume":"20","author":"Jiang","year":"2020","journal-title":"Nano Lett."},{"issue":"42","key":"10.1016\/j.jconrel.2026.115061_bb0070","doi-asserted-by":"crossref","first-page":"29045","DOI":"10.1021\/acsnano.4c10154","article-title":"Tetrahydropyrimidine Ionizable lipids for efficient mRNA delivery","volume":"18","author":"Isaac","year":"2024","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115061_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"31","key":"10.1016\/j.jconrel.2026.115061_bb0080","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1021\/jacs.1c05813","article-title":"One-component multifunctional sequence-defined ionizable amphiphilic Janus dendrimer delivery systems for mRNA","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115061_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Molecular therapy Methods & clinical development."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0100","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41467-023-39768-9","article-title":"Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115061_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115147","article-title":"Emerging delivery approaches for targeted pulmonary fibrosis treatment","volume":"204","author":"Diwan","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115061_bb0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer Progress and priorities: lung Cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer epidemiology, biomarkers & prevention"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115061_bb0115","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1152\/physrev.00032.2017","article-title":"Integrative physiology of pneumonia","volume":"98","author":"Quinton","year":"2018","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115061_bb0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3201\/eid0503.990308","article-title":"Respiratory diseases among U.S. military personnel: countering emerging threats","volume":"5","author":"Gray","year":"1999","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0125","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.jconrel.2026.115061_bb0130","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1021\/acs.nanolett.4c01854","article-title":"Lung-specific mRNA delivery enabled by sulfonium lipid nanoparticles","volume":"24","author":"Popoola","year":"2024","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115061_bb0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115061_bb0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115061_bb0145","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1021\/nn203745n","article-title":"In vivo sustained release of siRNA from solid lipid nanoparticles","volume":"5","author":"Lobovkina","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115061_bb0150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"Journal of controlled release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219869","article-title":"Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity","volume":"30","author":"Wang","year":"2023","journal-title":"Drug Deliv."},{"issue":"26","key":"10.1016\/j.jconrel.2026.115061_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Advanced materials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/mp500604r","article-title":"Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro","volume":"12","author":"Betker","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115061_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods. Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.jconrel.2026.115061_bb0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2025.01.010","article-title":"Structural and functional characterization of a histidylated liposome for mRNA delivery","volume":"379","author":"Ngalle Loth","year":"2025","journal-title":"Journal of controlled release"},{"key":"10.1016\/j.jconrel.2026.115061_bb0180","article-title":"Tissue-specific mRNA delivery and prime editing with peptide-ionizable lipid nanoparticles","author":"Lin","year":"2025","journal-title":"Nat. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115061_bb0185","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/chir.23509","article-title":"Hydrothermal synthesis of chiral carbon dots","volume":"34","author":"Visheratina","year":"2022","journal-title":"Chirality"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115061_bb0190","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1021\/acsnano.3c10792","article-title":"High quantum yield amino acid carbon quantum dots with unparalleled refractive index","volume":"18","author":"Kumar","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115061_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125745","article-title":"Boron-doped carbon quantum dots: a biocompatible nanoplatform for targeted cancer theranostics","volume":"679","author":"G\u00fcven","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115061_bb0200","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41551-020-0540-y","article-title":"Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids","volume":"4","author":"Li","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115061_bb0205","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/s41467-025-57531-0","article-title":"Sterically chained amino acid-rich water-soluble carbon quantum dots as a robust tumor-targeted drug delivery platform","volume":"16","author":"Xie","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:43:07Z","timestamp":1787578987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S0168365926004645"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115061","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving the goldilocks zone of lung-targeted mRNA delivery with a charge-steric optimized quantum dot-lipid system for pulmonary fibrosis therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115061"}}